IS5024A - Lyfjasamsetningar sem innihalda lamivúdín og zídóvúdín - Google Patents

Lyfjasamsetningar sem innihalda lamivúdín og zídóvúdín

Info

Publication number: IS5024A
Authority: IS; Iceland
Prior art keywords: zidovudine; pharmaceutical formulations; formulations containing; containing lamivudine; lamivudine
Prior art date: 1996-10-31

Application number

IS5024A

Other languages

English (en)

Inventor

Wayne Goodson Gary

Wayne Wood Allen

Jeannette Ford Katherine

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-31

Filing date

1999-04-09

Publication date

1999-04-09

1999-04-09 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

1999-04-09 Publication of IS5024A publication Critical patent/IS5024A/is

Links

LHCOVOKZWQYODM-CPEOKENHSA-N 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 LHCOVOKZWQYODM-CPEOKENHSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Biotechnology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)

IS5024A 1996-10-31 1999-04-09 Lyfjasamsetningar sem innihalda lamivúdín og zídóvúdín IS5024A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9622681.6A GB9622681D0 (en)	1996-10-31	1996-10-31	Pharmaceutical compositions
PCT/EP1997/005953 WO1998018477A2 (en)	1996-10-31	1997-10-29	Pharmaceutical compositions containing lamivudine and zidovudine

Publications (1)

Publication Number	Publication Date
IS5024A true IS5024A (is)	1999-04-09

Family

ID=10802224

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5024A IS5024A (is)	1996-10-31	1999-04-09	Lyfjasamsetningar sem innihalda lamivúdín og zídóvúdín

Country Status (43)

Country	Link
EP (1)	EP0941100B1 (is)
JP (1)	JP2001502718A (is)
KR (1)	KR100551652B1 (is)
AP (1)	AP1067A (is)
AR (1)	AR009135A1 (is)
AT (1)	ATE241364T1 (is)
AU (1)	AU736607B2 (is)
BG (1)	BG64541B1 (is)
BR (1)	BR9712614A (is)
CA (1)	CA2270174A1 (is)
CO (1)	CO4930269A1 (is)
CY (1)	CY2485B1 (is)
CZ (1)	CZ296080B6 (is)
DE (1)	DE69722433T2 (is)
DK (1)	DK0941100T3 (is)
EA (1)	EA002437B1 (is)
EE (1)	EE03806B1 (is)
ES (1)	ES2200204T3 (is)
GB (1)	GB9622681D0 (is)
GE (1)	GEP20022735B (is)
GT (1)	GT199700116A (is)
HR (1)	HRP970569B1 (is)
HU (1)	HU224969B1 (is)
ID (1)	ID18698A (is)
IL (1)	IL129422A0 (is)
IS (1)	IS5024A (is)
MY (1)	MY119513A (is)
NO (1)	NO317163B1 (is)
NZ (1)	NZ335153A (is)
OA (1)	OA11038A (is)
PA (1)	PA8441101A1 (is)
PE (1)	PE10099A1 (is)
PL (1)	PL190349B1 (is)
PT (1)	PT941100E (is)
SI (1)	SI0941100T1 (is)
SK (1)	SK284286B6 (is)
SV (1)	SV1997000090A (is)
TR (1)	TR199900950T2 (is)
UA (1)	UA64725C2 (is)
UY (1)	UY24766A1 (is)
WO (1)	WO1998018477A2 (is)
YU (1)	YU19999A (is)
ZA (1)	ZA979726B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
EP1501521B1 (en) *	2002-04-23	2007-05-02	Lupin Limited	Long acting compositions comprising zidovudine and/or lamivudine
JP2006508134A (ja) *	2002-11-08	2006-03-09	グラクソ　グループ　リミテッド	医薬組成物
SI1583542T1 (sl)	2003-01-14	2008-12-31	Gilead Sciences Inc	Sestavki in postopki za kombinacijsko antivirusnoterapijo
AR045841A1 (es) *	2004-09-28	2005-11-16	Richmond Sa Com Ind Y Financie	Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r, 8r, 10r,11r)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
CN114010776A (zh)	2010-06-09	2022-02-08	疫苗技术股份有限公司	用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
RU2014140177A (ru)	2012-03-05	2016-04-27	Сипла Лимитед	Фармацевтические антиретровирусные композиции
EP2958563A2 (en) *	2013-02-20	2015-12-30	AbbVie Inc.	Tablet dosage form comprising ritonavir and lopinavir

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4950652A (en) *	1987-03-23	1990-08-21	Hem Research, Inc.	dsRNAs for combination therapy in the treatment of viral diseases
DK0513917T4 (da) *	1991-05-16	2001-06-25	Glaxo Group Ltd	Antivirale kombinationer indeholdende nukleosidanaloger
GB9110624D0 (en) *	1991-05-16	1991-07-03	Glaxo Group Ltd	Combinations
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions

1996
- 1996-10-31 GB GBGB9622681.6A patent/GB9622681D0/en active Pending
1997
- 1997-10-24 HR HR970569A patent/HRP970569B1/xx not_active IP Right Cessation
- 1997-10-28 CO CO97063174A patent/CO4930269A1/es unknown
- 1997-10-28 SV SV1997000090A patent/SV1997000090A/es not_active Application Discontinuation
- 1997-10-28 MY MYPI97005103A patent/MY119513A/en unknown
- 1997-10-29 WO PCT/EP1997/005953 patent/WO1998018477A2/en not_active Ceased
- 1997-10-29 DK DK97950036T patent/DK0941100T3/da active
- 1997-10-29 EA EA199900345A patent/EA002437B1/ru not_active IP Right Cessation
- 1997-10-29 TR TR1999/00950T patent/TR199900950T2/xx unknown
- 1997-10-29 GE GEAP19974781A patent/GEP20022735B/en unknown
- 1997-10-29 UA UA99042239A patent/UA64725C2/uk unknown
- 1997-10-29 AT AT97950036T patent/ATE241364T1/de active
- 1997-10-29 PE PE1997000965A patent/PE10099A1/es not_active Application Discontinuation
- 1997-10-29 PT PT97950036T patent/PT941100E/pt unknown
- 1997-10-29 EP EP97950036A patent/EP0941100B1/en not_active Expired - Lifetime
- 1997-10-29 DE DE69722433T patent/DE69722433T2/de not_active Expired - Lifetime
- 1997-10-29 IL IL12942297A patent/IL129422A0/xx not_active IP Right Cessation
- 1997-10-29 AR ARP970105027A patent/AR009135A1/es unknown
- 1997-10-29 CA CA002270174A patent/CA2270174A1/en not_active Abandoned
- 1997-10-29 NZ NZ335153A patent/NZ335153A/en unknown
- 1997-10-29 KR KR1019997003757A patent/KR100551652B1/ko not_active Expired - Fee Related
- 1997-10-29 AU AU53142/98A patent/AU736607B2/en not_active Ceased
- 1997-10-29 CZ CZ0155799A patent/CZ296080B6/cs not_active IP Right Cessation
- 1997-10-29 GT GT199700116A patent/GT199700116A/es unknown
- 1997-10-29 SK SK575-99A patent/SK284286B6/sk unknown
- 1997-10-29 BR BR9712614-4A patent/BR9712614A/pt not_active IP Right Cessation
- 1997-10-29 ZA ZA979726A patent/ZA979726B/xx unknown
- 1997-10-29 ES ES97950036T patent/ES2200204T3/es not_active Expired - Lifetime
- 1997-10-29 JP JP10520045A patent/JP2001502718A/ja active Pending
- 1997-10-29 EE EEP199900175A patent/EE03806B1/xx not_active IP Right Cessation
- 1997-10-29 AP APAP/P/1999/001519A patent/AP1067A/en active
- 1997-10-29 PL PL97333143A patent/PL190349B1/pl unknown
- 1997-10-29 YU YU19999A patent/YU19999A/sh unknown
- 1997-10-29 SI SI9730570T patent/SI0941100T1/xx unknown
- 1997-10-29 HU HU0000344A patent/HU224969B1/hu not_active IP Right Cessation
- 1997-10-30 PA PA19978441101A patent/PA8441101A1/es unknown
- 1997-10-30 ID IDP973554A patent/ID18698A/id unknown
- 1997-10-30 UY UY24766A patent/UY24766A1/es not_active IP Right Cessation
1999
- 1999-04-09 IS IS5024A patent/IS5024A/is unknown
- 1999-04-23 OA OA9900088A patent/OA11038A/en unknown
- 1999-04-29 NO NO19992091A patent/NO317163B1/no unknown
- 1999-05-26 BG BG103435A patent/BG64541B1/bg unknown
2004
- 2004-11-26 CY CY0400085A patent/CY2485B1/xx unknown

Also Published As

Publication number	Publication date
PT941100E (pt)	2003-10-31
EA002437B1 (ru)	2002-04-25
CY2485B1 (en)	2005-06-03
HK1020880A1 (en)	2000-05-26
GT199700116A (es)	1999-04-22
WO1998018477A3 (en)	1998-06-18
AP9901519A0 (en)	1999-06-30
EE9900175A (et)	1999-12-15
NO992091L (no)	1999-06-29
AU736607B2 (en)	2001-08-02
PE10099A1 (es)	1999-03-02
NO992091D0 (no)	1999-04-29
SK284286B6 (sk)	2005-01-03
AU5314298A (en)	1998-05-22
ATE241364T1 (de)	2003-06-15
SI0941100T1 (en)	2003-12-31
NO317163B1 (no)	2004-08-30
SK57599A3 (en)	2000-06-12
HU224969B1 (en)	2006-04-28
PA8441101A1 (es)	2000-05-24
CA2270174A1 (en)	1998-05-07
ID18698A (id)	1998-04-30
WO1998018477A2 (en)	1998-05-07
HRP970569B1 (en)	2004-10-31
JP2001502718A (ja)	2001-02-27
GB9622681D0 (en)	1997-01-08
EP0941100A2 (en)	1999-09-15
HUP0000344A3 (en)	2002-04-29
BR9712614A (pt)	1999-10-26
YU19999A (sh)	2000-10-30
SV1997000090A (es)	1998-10-07
HRP970569A2 (en)	1998-08-31
ZA979726B (en)	1999-04-29
ES2200204T3 (es)	2004-03-01
KR20000052893A (ko)	2000-08-25
DE69722433T2 (de)	2004-04-08
OA11038A (en)	2002-02-06
PL190349B1 (pl)	2005-11-30
HUP0000344A2 (hu)	2001-05-28
DE69722433D1 (de)	2003-07-03
CO4930269A1 (es)	2000-06-27
KR100551652B1 (ko)	2006-02-13
CZ155799A3 (cs)	1999-10-13
UA64725C2 (uk)	2004-03-15
PL333143A1 (en)	1999-11-22
BG103435A (en)	2000-04-28
EE03806B1 (et)	2002-08-15
EP0941100B1 (en)	2003-05-28
BG64541B1 (bg)	2005-07-29
DK0941100T3 (da)	2003-09-01
NZ335153A (en)	2001-04-27
CZ296080B6 (cs)	2006-01-11
MY119513A (en)	2005-06-30
AP1067A (en)	2002-05-01
EA199900345A1 (ru)	2000-02-28
GEP20022735B (en)	2002-07-25
UY24766A1 (es)	2000-12-29
AR009135A1 (es)	2000-03-08
TR199900950T2 (xx)	1999-07-21
IL129422A0 (en)	2000-02-17

Publication	Publication Date	Title
NO20002359L (no)	2000-07-05	Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
HUP0000065A3 (en)	2000-11-28	Olanzapine dihydrate d and pharmaceutical compositions containing the same
DK0850059T3 (da)	2003-03-31	Farmaceutiske formuleringer indeholdende darifenacin
EE9700138A (et)	1997-12-15	Aerosoolravimvormid
HUP0001309A3 (en)	2000-12-28	1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
PT932397E (pt)	2006-07-31	Formulacoes em aerossol medicinais compreendendo budesonida
DE69904262D1 (de)	2003-01-16	Benzylalkohol enthaltene FSH und FSH-Varianten Formulierungen
DK0804078T3 (da)	2000-04-10	Sammensætning og anvendelse deraf
PL343710A1 (en)	2001-08-27	Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine
NO965023L (no)	1996-11-26	Maltitolblanding og fremstilling derav
HUP0101701A3 (en)	2003-02-28	Substituted betha-alanines and pharmaceutical compositions comprising them
IS5024A (is)	1999-04-09	Lyfjasamsetningar sem innihalda lamivúdín og zídóvúdín
ID16781A (id)	1997-11-13	Formulasi-formulasi farmasi
IL125908A0 (en)	1999-04-11	Peptides and pharmaceutical compositions comprising same
HUP0000460A3 (en)	2001-04-28	Imidazopyridazines and pharmaceutical compositions thereof
ITMI941169A0 (it)	1994-06-06	Formulazioni farmaceutiche
EP0837863A4 (en)	1999-06-16	DISODIUM ALENDRONATE PREPARATIONS
DE69731493D1 (de)	2004-12-09	Analoger FIFO-Speicher
NO983346L (no)	1998-09-17	Tamoxifen og analoger derav
GB9606372D0 (en)	1996-06-05	Pharmaceutical formulations
GB9621531D0 (en)	1996-12-04	Pharmaceutical formulations
GB9700523D0 (en)	1997-02-26	Medicinal interest compositions
GB9701260D0 (en)	1997-03-12	Medicinal interest compositions
BR1100391A (pt)	2002-04-09	Composto e composição farmacêutica
GB9607110D0 (en)	1996-06-12	Benzothiopenes formulations containing same and methods